冠心病心绞痛患者中医证候与相关血清蛋白表达的研究
|
摘要
背景：随着社会经济的发展和人们生活方式的改变,冠心病心绞痛的发病率逐年提高,已经成为影响人类寿命和生存质量的主要疾病之一。对其进行研究具有重要的社会意义和卫生经济学意义。中医药治疗慢性稳定性心绞痛具有独特的价值,然其证候规律、证候的临床特征、产生机理及预后价值尚缺乏统一认识,有待于进一步研究,为冠心病、心绞痛中医证候的临床诊断、辨证论治提供依据,以利于充分发挥中医药优势。
目的：探讨冠心病心绞痛中医常见证候临床表现特征与相关血清蛋白质表达的关系。
方法：
1.冠心病稳定性心绞痛患者临床中医证候学研究：分析经冠状动脉造影证实的冠心病稳定性心绞痛患者临床证候学特点,包括冠心病心绞痛患者证候要素及常见证候分布特点,观察常见证候及证候要素之间危险因素、冠脉病变程度的差异；采用MDR方法初步构建相关模型,计算冠心病心绞痛患者临床表现与证候要素、常见证候之间的关系。
2.冠心病稳定性心绞痛患者相关蛋白质表达与证候关系研究：采用液相蛋白芯片分析方法同步检测冠心病心绞痛患者血清sE-Selectin, sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1含量,统计证候要素、常见证候之间上述蛋白质表达差异,研究证候要素、常见证候与血清蛋白质表达的关系。
结果：
1.冠心病稳定性心绞痛患者临床经常出现的证候要素分布为痰147例次、瘀145例次、气虚115例次、阴虚73例次、气滞14例次、阳虚24例次、热22例次、寒4例次；常见证候有气虚血瘀证85例次、痰瘀互结证92例次、阴虚痰阻证56例次、气虚痰阻证86例次、气滞血瘀证14例次、阴虚血瘀证40例次、阳虚痰阻证15、气虚血瘀痰阻证56例次、气阴两虚痰阻证42例次、气阴两虚痰瘀证21例次。不同证候之间,患者冠心病危险因素、冠脉病变程度差异均无显著的统计学意义。
2.冠心病心绞痛患者证候要素、常见证候的临床表现特征：寒(头晕、心悸、情志抑郁和脉络形态),准确性,0.884,敏感性,1.000,特异性,0.881,预测准确性, 0.143；气虚,(面色淡白、心痛如刺、唇舌紫暗、腰酸),准确性,0.718,敏感性,0.722,特异性,0.714,预测准确性,0.762；气滞,(善太息、心痛如刺、下肢浮肿、舌质斑点或瘀斑)准确性,0.786,敏感性,1,特异性,0.771,预测准确性,0.241；热,(心悸、唇色紫暗、舌下脉络颜色、脘腹痞闷),准确性,0.704,敏感性,0.909,特异性,0.679,预测准确性,0.253;痰,(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),准确性,0.762,敏感性,0.748,特异性,0.797,预测准确性,0.902；阳虚,(脘腹痞闷、舌下脉络颜色、唇舌紫暗、心悸)准确性,0.704,敏感性,0.875,特异性,0.681,预测准确性,0.266；阴虚,(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),准确性,0.728,敏感性,0.795,特异性,0.692,预测准确性,0.586；瘀,(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗)；准确性,0.7476,敏感性,0.731,特异性,0.7869,预测准确性,0.8908；气虚血瘀,(便秘、心悸、舌下脉络形态、体胖多痰)准确性,0.8204,敏感性,0.8947,特异性,0.8128,预测准确性,0.3269；痰瘀互结,(便秘、心悸、舌下脉络形态、体胖多痰),准确性,0.7718,敏感性,1,特异性,0.759,预测准确性,0.1897；阴虚痰阻,(心悸、体胖多痰、便秘、舌下脉络形态)准确性,0.825,敏感性,1.000,特异性,0.818,预测准确性,0.182；气虚痰阻,(心胸胀痛、五心烦热、善太息、情志抑郁),准确性,0.898,敏感性,1.000,特异性,0.895,预测准确性,0.250；气滞血瘀,神疲、心胸胀痛、舌下脉络形态、细脉),准确性,0.854,敏感性,1.000,特异性,0.849,预测准确性,0.189；阴虚血瘀,(心悸、体胖多痰、便秘、脉络),准确性,0.854,敏感性,1.000,特异性,0.849,预测准确性,0.189；阳虚痰阻,(心悸、体胖多痰、便秘、舌下脉络形态),准确性,0.864,敏感性,1.000,特异性,0.859,预测准确性,0.200；气虚血瘀痰阻,(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),准确性,0.7476,敏感性,0.8529,特异性,0.7267,预测准确性,0.3816；气阴两虚痰阻,(心悸、体胖多痰、舌下脉络形态、便秘)准确性,0.830,敏感性,1.000,特异性,0.816,预测准确性,0.314；气阴两虚痰瘀证,(体胖多痰、心胸胀痛、舌苔色白和面色淡白),准确性,0.811,敏感性,0.950,特异性,0.796,预测准确性,0.333。
3.冠心病稳定性心绞痛患者血清sVCAM-1(ln), sICAM-1(ln), MMP-9(ln), MPO(ln), tPAI-1蛋白表达均显著高于健康对照组,p值均<0.01,sE-selectin (In)在稳定性心绞痛患者和健康对照组的表达差异没有显著的统计学意义(p=0.067)。
4.相关血清蛋白在冠心病心绞痛各证候要素中表达：tPAI-1在痰、瘀、气虚、阴虚、热证候要素中升高；sVCAM-1在痰、瘀、气虚、气滞、阴虚、热证候要素中升高；sICAM在痰、瘀、气虚、气滞、阴虚、热证候要素中升高；MMP-9在痰、瘀、气虚、气滞、阴虚、热证候要素中升高,sE-Selectin在痰、瘀、气虚、阴虚证候要素中升高；MPO在痰、瘀、气虚、气滞、阳虚、热证候要素中升高。
5.相关血清蛋白在冠心病心绞痛常见证候中表达：tPAI-1在气虚血瘀证、痰瘀互结证、阴虚痰阻证、气虚痰阻证、阴虚血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴虚两虚痰瘀证中表达升高较显著(p<0.01)；sVCAM-1在气虚血瘀证、痰瘀互结证、阴虚痰阻证、气虚痰阻证、阴虚血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴虚两虚痰瘀证中表达升高较显著(p<0.01)；sICAM在气虚血瘀证、痰瘀互结证、气虚痰阻证、气滞血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证表达较健康对照组及阳虚痰阻证显著升高(p<0.01)；MMP-9在气虚血瘀证、痰瘀互结证、气虚痰阻证、气滞血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证表达升高显著(p＜0.01或0.05)；sE-Selectin在气虚血瘀证、痰瘀互结证、气虚痰阻证、阴虚痰阻证、阴虚血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证显著高于健康对照组和阳虚痰阻证(p＜0.01)；MPO在气虚血瘀证、痰瘀互结证、气虚痰阻证、阴虚痰阻证、阴虚血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证表达均显著升高(p<0.01)。
结论：
1.冠心病稳定性心绞痛患者临床常见证候要素痰、瘀、气虚、阴虚、气滞、阳虚、热、寒；常见证候气虚血瘀证、痰瘀互结证、阴虚痰阻证、气虚痰阻证、气滞血瘀证、阴虚血瘀证、阳虚痰阻证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证。
2.冠心病心绞痛证候要素临床表现特征：寒(头晕、心悸、情志抑郁和脉络形态),气虚(面色淡白、心痛如刺、唇舌紫暗、腰酸),气滞(善太息、心痛如刺、下肢浮肿、舌质斑点或瘀斑),热(心悸、唇色紫暗、舌下脉络颜色、脘腹痞闷),痰(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),阳虚(脘腹痞闷、舌下脉络颜色、唇舌紫暗、心悸),阴虚(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),血瘀(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗)。
3.冠心病心绞痛常见证候临床表现特征：气虚血瘀(便秘、心悸、舌下脉络形态、体胖多痰),痰瘀互结(便秘、心悸、舌下脉络形态、体胖多痰),阴虚痰阻(心悸、体胖多痰、便秘、舌下脉络形态),气虚痰阻(心胸胀痛、五心烦热、善太息、情志抑郁),气滞血瘀(神疲、心胸胀痛、舌下脉络形态、细脉),阴虚血瘀(心悸、体胖多痰、便秘、脉络),阳虚痰阻(心悸、体胖多痰、便秘、舌下脉络形态),气虚血瘀痰阻(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),气阴两虚痰阻(心悸、体胖多痰、舌下脉络形态、便秘),气阴两虚痰瘀证(体胖多痰、心胸胀痛、舌苔色白和面色淡白)。
4.冠心病稳定性心绞痛患者血清sVCAM-1(ln), sICAM-1(ln), MMP-9(ln), MPO(ln), tPAI-1蛋白均显著高于健康对照组。
5.冠心病稳定性心绞痛证候要素中,痰、瘀、气虚、阴虚、热证素的血清tPAI-1、sVCAM-1、sICAM-1、sE-selectin、MMP-9、MPO蛋白表达升高；气滞证素血清sVCAM-1、MMP-9、MPO蛋白表达升高；阳虚证素MPO蛋白表达升高；
6.冠心病稳定性心绞痛常见证候中气虚血瘀、痰瘀互结、阴虚痰阻、气虚痰阻、阴虚血瘀证候的血清tPAI-1、sVCAM-1、sICAM-1、sE-selectin、MMP-9、MPO蛋白表达升高；气滞血瘀证候血清sVCAM-1、sICAM-1、MMP-9、MPO蛋白表达升高；气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证证候tPAI-1、sVCAM-1、sICAM-1、sE-selectin、MMP-9、MPO蛋白表达升高。
Background: With the development of social economic and the change of people's lifestyles, the incidence of angina pectoris increases year by year, and become one of the main diseases which impact on the life expectancy and quality of life. Therefore, it is of great importance on social meaning and health economics meaning to research the disease of angina pectoris. Traditional Chinese medicine plays a unique value in treating chronic stable angina, but the law of syndrome, generation mechanism prognostic value needs to be further researched to give full play to TCM and to provide basis for the syndrome differentiation and clinical diagnosis of angina pectoris.
Objective:To discuss the relationship between common clinical manifestation and related serum protein expression in angina pectoris.
Methods:
1. Clinical syndrome in patients with coronary stable angina cordis: patients with coronary stable angina cordis proved by coronal artery angiography were analyzed the characters of clinical syndrome. The character included syndrome elements, the common syndrome distribution, the risk factor between common syndrome and syndrome elements, the differences of coronary angiographic degree. The relative model was built by using MDR, and then calculated the relationship between clinical manifestation and syndrome of patients with angina pectoris.
2. The relationship between protein expression and syndrome in patients with coronary stable angina cordis:the content of Se-Selectin, sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1 was detected by analysis of liquid protein chip, statisticed the protein differential expressions in syndrome elements and common syndrome, researched the relationship among syndrome elements, common syndrome and protein expression.
Results:
1.The distribution of common syndrome elements in patients with coronary stable angina cordis shows that 147 cases of phlegm,145 cases of stasis,115 cases of qi deficiency,73 cases of yin deficiency,14 cases of qi stagnation,24 cases of yang deficiency,22 cases of heat,4 cases of cold. The common syndrome shows that 85 cases of qi deficiency and blood stasis,92 cases of phlegm and blood stasis,56 cases of yin deficiency and phlegm obstruction,86 cases of qi deficiency and phlegm obstruction,42 cases of both qi and yin deficiency and phlegm obstruction,21 cases of both qi and yin deficiency and phlegm stasis. Compare with different syndrome, there is no statistically significance in risk factor and coronary angiographic degree.
2. The characteristic of syndrome elements and common syndrome in patients with angina pectoris:for cold (dizziness, palpitation, depression, the shape of choroids) the accuracy was 0.884, sensitivity was 1.000, specifty was 0.881 and the predicative accuracy was 0.143; for qi deficiency (pale complexion, stabbing pain in the chest, cyanotic lips and tongue, soreness) the accuracy was 0.718, sensitivity was 0.722, specifty was0.741 and the predicative accuracy was 0.762; for qi stagnation, (preference for sighing, stabbing pain in the chest, edema of both lower limbs, purplish grayish tongue) the accuracy was 0.786, sensitivity was 1, specifty was0.771and the predicative accuracy was 0.241; for heat(palpitation, cyanotic lips and tongue, the color of sublingual vein, abdominal distension) the accuracy was 0.704, sensitivity was 0.909, specifty was0.679and the predicative accuracy was 0.253; for phlegm(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.762, sensitivity was 0.748, specifty was0.797and the predicative accuracy was 0.902;for yang deficiency(abdominal distension, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.704, sensitivity was 0.875, specifty was0.681and the predicative accuracy was 0.266;for yin deficiency(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.728, sensitivity was 0.795, specifty was0.692and the predicative accuracy was 0.586; for blood stasis(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.7476, sensitivity was 0.731, specifty was0.7869and the predicative accuracy was 0.8908; for qi deficiency and blood stasis (constipation, palpitation, the shape of choroids, fat body) the accuracy was 0.8204, sensitivity was 0.8947, specifty was0.8128and the predicative accuracy was 0.3269;for phlegm and blood stasis(constipation, palpitation, the shape of choroids, fat body) the accuracy was 0.7718, sensitivity was 1, specifty was0.759and the predicative accuracy was 0.1897; for yin deficiency and phlegm obstruction(constipation, palpitation, the shape of choroids, fat body) the accuracy was 0.825, sensitivity was 1.000, specifty was0.818, the predicative accuracy was 0.182; for qi deficiency and phlegm obstruction(dyspnea chest discomfort, buring sensation of five centers, preference for sighing,depression) the accuracy was 0.898, sensitivity was 1.000, specifty was 0.895 and the predicative accuracy was 0.250; for qi stagnation and blood stasis(dyspnea chest discomfort, buring sensation of five centers, preference for sighing,depression) the accuracy was 0.854, sensitivity was 1.000, specifty was 0.849 and the predicative accuracy was 0.189;for yin-asthenia and blood-stasis(palpitation, overweight and phlegmatic, constipation, thread of thought) the accuracy was 0.854, sensitivity was 1.000, specifty was 0.849 and the predicative accuracy was 0.189;for yang deficiency and phlegm obstruction(palpitation, overweight and phlegmatic, constipation, the shape of choroids) the accuracy was 0.864, sensitivity was 1.000, specifty was 0.859 and the predicative accuracy was 0.200;for qi deficiency and blood stasis and phlegm obstruction(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.7476, sensitivity was 0.8529, specifty was 0.7267 and the predicative accuracy was 0.3816;for both of qi and yin deficiency and phlegm obstruction(palpitation, overweight and phlegmatic, constipation, the shape of choroids) the accuracy was 0.830, sensitivity was 1.000, specifty was 0.816 and the predicative accuracy was 0.314;for both of deficiency and phlegm stasis(overweight and phlegmatic, dyspnea chest discomfort, whitish tongue fur and pale complexion) the accuracy was 0.811, sensitivity was 0.950, specifty was 0.796 and the predicative accuracy was 0.333.
3. The protein expression in sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1 in patients with coronary stable angina cordis is higher than health(P<0.01). There is no statistically meaning in sE-Selectin in both groups (p=0.067) 4. Protein expression of syndrome elements in patients with coronary stable angina cordis:The expression of tPAI-1 is higher in phlegm, stasis, qi deficiency, yin deficiency, heat; The expression of sVCAM-1 is higher in phlegm, stasis, qi deficiency, qi stagnation, yin deficiency, heat; the expression of sICAM-1 is higher in phlegm, stasis, qi deficiency, qi stagnation, yin deficiency, heat; The expression of MMP-9 is higher in phlegm, stasis, qi deficiency, qi stagnation, yin deficiency, heat; the expression of Se-Selectin is higher in phlegm, stasis, qi deficiency, yin deficiency; The expression of MPO is higher in phlegm, stasis, qi deficiency, qi stagnation, yang deficiency, heat.
5. Protein expression of syndrome in patients with coronary stable angina cordis:The expression of tPAI-1 is higher in qi deficiency and blood stasis, phlegm and blood stasis, yin deficiency and phlegm obstruction, qi deficiency and phlegm obstruction, yin deficiency and blood stasis; qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01); The expression of sVCAM-1 is higher in qi deficiency and blood stasis, phlegm and blood stasis, yin deficiency and phlegm obstruction, qi deficiency and phlegm obstruction, yin deficiency and blood stasis, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01); The expression of sICAM-1 is higher in qi deficiency and blood stasis, phlegm and blood stasis, yin deficiency and phlegm obstruction, qi deficiency and phlegm obstruction, yin deficiency and blood stasis, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01); The expression of MMP-9 is higher in qi deficiency and blood stasis, phlegm and blood stasis, phlegm and blood stasis, qi deficiency and phlegm obstruction, qi stagnation and blood stasis, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01or 0.05); The expression of Se-Selectin is higher in qi deficiency and blood stasis, phlegm and blood stasis, qi deficiency and phlegm obstruction, yin deficiency and phlegm obstruction, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01); The expression of Se-Selectin is higher than health and yang deficiency; The expression of MPO is higher in qi deficiency and blood stasis, phlegm and blood stasis, qi deficiency and phlegm obstruction, yin deficiency and phlegm obstruction, yin deficiency and blood stasis, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01);
Conclusion:
1.The common syndrome elements in patients with coronary stable angina cordis can be seen as phlegm, stasis, qi deficiency, yin deficiency, qi stagnation, yang deficiency, heat, cold; while the common syndrome can be seen as qi deficiency and blood stasis, phlegm and blood stasis, qi deficiency and phlegm obstruction, qi stagnation and blood stasis, yin deficiency and blood stasis, yang deficiency and phlegm obstruction, qi deficiency and blood stasis and phlegm obstruction, both of qi and yin deficiency and phlegm obstruction, both of qi and yin deficiency and phlegm stasis.
2.The clinical manifestation of syndrome elements in patients with coronary stable angina cordis can be summarized as following: cold(dizziness, palpitation, depression, stabbing pain in the chest, the shape of choroids); qi deficiency(pale complexion, stabbing pain in the chest, cyanotic lips and tongue, sorness); qi stagnation(preference for sighing, stabbing pain in the chest, edema of both lower limbs, purplish grayish tongue);heat (palpitation, cyanotic lips and tongue, the color of sublingual vein, abdominal distension); phlegm(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue);yang deficiency(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue);yin deficiency (abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue);blood stasis(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue);
3. The clinical manifestation of syndrome elements in patients with coronary stable angina cordis can be summarized as following: qi deficiency and blood stasis(constipation, fat body, palpitation, the shape of choroids); phlegm and blood stasis(constipation, fat body, palpitation, the shape of choroids);yin deficiency and phlegm obstruction(constipation, fat body, palpitation, the shape of choroids); yin deficiency and blood stasis(constipation, fat body, palpitation, the shape of choroids); qi deficiency and blood stasis and phlegm obstruction(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue); both of qi and yin deficiency and phlegm obstruction(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue, constipation); both of qi and yin deficiency and phlegm stasis(fat body, stabbing pain in the chest, pale complexion, pale tongue).
4. The content of sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1 in patients with coronary stable angina cordis is higher than health.
5. The expression of tPAI-1, sVCAM-1, sICAM-1, sE-Selectin, MMP-9, MPO, in phlegm, stasis, qi deficiency, yin deficiency and heat increase higher; while the expression of sVCAM-1,MMP-9, MPO in qi stagnation increased significantly; MPO in yang deficiency increased.
6.The expression of sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1,sE-Selectin in qi deficiency and blood stasis, phlegm and blood stasis, yin deficiency and phlegm obstruction, qi deficiency and phlegm obstruction, yin deficiency an blood stasis increased; while the expression of sVCAM-1, sICAM-1, MMP-9, MPO in qi stagnation and blood stasis increased higher; the expression of sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1,sE-Selectin in qi deficiency and blood stasis and phlegm obstruction, both of qi and yin deficiency and phlegm stasis increases higher.
目的：探讨冠心病心绞痛中医常见证候临床表现特征与相关血清蛋白质表达的关系。
方法：
1.冠心病稳定性心绞痛患者临床中医证候学研究：分析经冠状动脉造影证实的冠心病稳定性心绞痛患者临床证候学特点,包括冠心病心绞痛患者证候要素及常见证候分布特点,观察常见证候及证候要素之间危险因素、冠脉病变程度的差异；采用MDR方法初步构建相关模型,计算冠心病心绞痛患者临床表现与证候要素、常见证候之间的关系。
2.冠心病稳定性心绞痛患者相关蛋白质表达与证候关系研究：采用液相蛋白芯片分析方法同步检测冠心病心绞痛患者血清sE-Selectin, sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1含量,统计证候要素、常见证候之间上述蛋白质表达差异,研究证候要素、常见证候与血清蛋白质表达的关系。
结果：
1.冠心病稳定性心绞痛患者临床经常出现的证候要素分布为痰147例次、瘀145例次、气虚115例次、阴虚73例次、气滞14例次、阳虚24例次、热22例次、寒4例次；常见证候有气虚血瘀证85例次、痰瘀互结证92例次、阴虚痰阻证56例次、气虚痰阻证86例次、气滞血瘀证14例次、阴虚血瘀证40例次、阳虚痰阻证15、气虚血瘀痰阻证56例次、气阴两虚痰阻证42例次、气阴两虚痰瘀证21例次。不同证候之间,患者冠心病危险因素、冠脉病变程度差异均无显著的统计学意义。
2.冠心病心绞痛患者证候要素、常见证候的临床表现特征：寒(头晕、心悸、情志抑郁和脉络形态),准确性,0.884,敏感性,1.000,特异性,0.881,预测准确性, 0.143；气虚,(面色淡白、心痛如刺、唇舌紫暗、腰酸),准确性,0.718,敏感性,0.722,特异性,0.714,预测准确性,0.762；气滞,(善太息、心痛如刺、下肢浮肿、舌质斑点或瘀斑)准确性,0.786,敏感性,1,特异性,0.771,预测准确性,0.241；热,(心悸、唇色紫暗、舌下脉络颜色、脘腹痞闷),准确性,0.704,敏感性,0.909,特异性,0.679,预测准确性,0.253;痰,(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),准确性,0.762,敏感性,0.748,特异性,0.797,预测准确性,0.902；阳虚,(脘腹痞闷、舌下脉络颜色、唇舌紫暗、心悸)准确性,0.704,敏感性,0.875,特异性,0.681,预测准确性,0.266；阴虚,(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),准确性,0.728,敏感性,0.795,特异性,0.692,预测准确性,0.586；瘀,(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗)；准确性,0.7476,敏感性,0.731,特异性,0.7869,预测准确性,0.8908；气虚血瘀,(便秘、心悸、舌下脉络形态、体胖多痰)准确性,0.8204,敏感性,0.8947,特异性,0.8128,预测准确性,0.3269；痰瘀互结,(便秘、心悸、舌下脉络形态、体胖多痰),准确性,0.7718,敏感性,1,特异性,0.759,预测准确性,0.1897；阴虚痰阻,(心悸、体胖多痰、便秘、舌下脉络形态)准确性,0.825,敏感性,1.000,特异性,0.818,预测准确性,0.182；气虚痰阻,(心胸胀痛、五心烦热、善太息、情志抑郁),准确性,0.898,敏感性,1.000,特异性,0.895,预测准确性,0.250；气滞血瘀,神疲、心胸胀痛、舌下脉络形态、细脉),准确性,0.854,敏感性,1.000,特异性,0.849,预测准确性,0.189；阴虚血瘀,(心悸、体胖多痰、便秘、脉络),准确性,0.854,敏感性,1.000,特异性,0.849,预测准确性,0.189；阳虚痰阻,(心悸、体胖多痰、便秘、舌下脉络形态),准确性,0.864,敏感性,1.000,特异性,0.859,预测准确性,0.200；气虚血瘀痰阻,(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),准确性,0.7476,敏感性,0.8529,特异性,0.7267,预测准确性,0.3816；气阴两虚痰阻,(心悸、体胖多痰、舌下脉络形态、便秘)准确性,0.830,敏感性,1.000,特异性,0.816,预测准确性,0.314；气阴两虚痰瘀证,(体胖多痰、心胸胀痛、舌苔色白和面色淡白),准确性,0.811,敏感性,0.950,特异性,0.796,预测准确性,0.333。
3.冠心病稳定性心绞痛患者血清sVCAM-1(ln), sICAM-1(ln), MMP-9(ln), MPO(ln), tPAI-1蛋白表达均显著高于健康对照组,p值均<0.01,sE-selectin (In)在稳定性心绞痛患者和健康对照组的表达差异没有显著的统计学意义(p=0.067)。
4.相关血清蛋白在冠心病心绞痛各证候要素中表达：tPAI-1在痰、瘀、气虚、阴虚、热证候要素中升高；sVCAM-1在痰、瘀、气虚、气滞、阴虚、热证候要素中升高；sICAM在痰、瘀、气虚、气滞、阴虚、热证候要素中升高；MMP-9在痰、瘀、气虚、气滞、阴虚、热证候要素中升高,sE-Selectin在痰、瘀、气虚、阴虚证候要素中升高；MPO在痰、瘀、气虚、气滞、阳虚、热证候要素中升高。
5.相关血清蛋白在冠心病心绞痛常见证候中表达：tPAI-1在气虚血瘀证、痰瘀互结证、阴虚痰阻证、气虚痰阻证、阴虚血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴虚两虚痰瘀证中表达升高较显著(p<0.01)；sVCAM-1在气虚血瘀证、痰瘀互结证、阴虚痰阻证、气虚痰阻证、阴虚血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴虚两虚痰瘀证中表达升高较显著(p<0.01)；sICAM在气虚血瘀证、痰瘀互结证、气虚痰阻证、气滞血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证表达较健康对照组及阳虚痰阻证显著升高(p<0.01)；MMP-9在气虚血瘀证、痰瘀互结证、气虚痰阻证、气滞血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证表达升高显著(p＜0.01或0.05)；sE-Selectin在气虚血瘀证、痰瘀互结证、气虚痰阻证、阴虚痰阻证、阴虚血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证显著高于健康对照组和阳虚痰阻证(p＜0.01)；MPO在气虚血瘀证、痰瘀互结证、气虚痰阻证、阴虚痰阻证、阴虚血瘀证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证表达均显著升高(p<0.01)。
结论：
1.冠心病稳定性心绞痛患者临床常见证候要素痰、瘀、气虚、阴虚、气滞、阳虚、热、寒；常见证候气虚血瘀证、痰瘀互结证、阴虚痰阻证、气虚痰阻证、气滞血瘀证、阴虚血瘀证、阳虚痰阻证、气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证。
2.冠心病心绞痛证候要素临床表现特征：寒(头晕、心悸、情志抑郁和脉络形态),气虚(面色淡白、心痛如刺、唇舌紫暗、腰酸),气滞(善太息、心痛如刺、下肢浮肿、舌质斑点或瘀斑),热(心悸、唇色紫暗、舌下脉络颜色、脘腹痞闷),痰(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),阳虚(脘腹痞闷、舌下脉络颜色、唇舌紫暗、心悸),阴虚(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),血瘀(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗)。
3.冠心病心绞痛常见证候临床表现特征：气虚血瘀(便秘、心悸、舌下脉络形态、体胖多痰),痰瘀互结(便秘、心悸、舌下脉络形态、体胖多痰),阴虚痰阻(心悸、体胖多痰、便秘、舌下脉络形态),气虚痰阻(心胸胀痛、五心烦热、善太息、情志抑郁),气滞血瘀(神疲、心胸胀痛、舌下脉络形态、细脉),阴虚血瘀(心悸、体胖多痰、便秘、脉络),阳虚痰阻(心悸、体胖多痰、便秘、舌下脉络形态),气虚血瘀痰阻(脘腹痞闷、心悸、舌下脉络颜色、唇舌紫暗),气阴两虚痰阻(心悸、体胖多痰、舌下脉络形态、便秘),气阴两虚痰瘀证(体胖多痰、心胸胀痛、舌苔色白和面色淡白)。
4.冠心病稳定性心绞痛患者血清sVCAM-1(ln), sICAM-1(ln), MMP-9(ln), MPO(ln), tPAI-1蛋白均显著高于健康对照组。
5.冠心病稳定性心绞痛证候要素中,痰、瘀、气虚、阴虚、热证素的血清tPAI-1、sVCAM-1、sICAM-1、sE-selectin、MMP-9、MPO蛋白表达升高；气滞证素血清sVCAM-1、MMP-9、MPO蛋白表达升高；阳虚证素MPO蛋白表达升高；
6.冠心病稳定性心绞痛常见证候中气虚血瘀、痰瘀互结、阴虚痰阻、气虚痰阻、阴虚血瘀证候的血清tPAI-1、sVCAM-1、sICAM-1、sE-selectin、MMP-9、MPO蛋白表达升高；气滞血瘀证候血清sVCAM-1、sICAM-1、MMP-9、MPO蛋白表达升高；气虚血瘀痰阻证、气阴两虚痰阻证、气阴两虚痰瘀证证候tPAI-1、sVCAM-1、sICAM-1、sE-selectin、MMP-9、MPO蛋白表达升高。
Background: With the development of social economic and the change of people's lifestyles, the incidence of angina pectoris increases year by year, and become one of the main diseases which impact on the life expectancy and quality of life. Therefore, it is of great importance on social meaning and health economics meaning to research the disease of angina pectoris. Traditional Chinese medicine plays a unique value in treating chronic stable angina, but the law of syndrome, generation mechanism prognostic value needs to be further researched to give full play to TCM and to provide basis for the syndrome differentiation and clinical diagnosis of angina pectoris.
Objective:To discuss the relationship between common clinical manifestation and related serum protein expression in angina pectoris.
Methods:
1. Clinical syndrome in patients with coronary stable angina cordis: patients with coronary stable angina cordis proved by coronal artery angiography were analyzed the characters of clinical syndrome. The character included syndrome elements, the common syndrome distribution, the risk factor between common syndrome and syndrome elements, the differences of coronary angiographic degree. The relative model was built by using MDR, and then calculated the relationship between clinical manifestation and syndrome of patients with angina pectoris.
2. The relationship between protein expression and syndrome in patients with coronary stable angina cordis:the content of Se-Selectin, sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1 was detected by analysis of liquid protein chip, statisticed the protein differential expressions in syndrome elements and common syndrome, researched the relationship among syndrome elements, common syndrome and protein expression.
Results:
1.The distribution of common syndrome elements in patients with coronary stable angina cordis shows that 147 cases of phlegm,145 cases of stasis,115 cases of qi deficiency,73 cases of yin deficiency,14 cases of qi stagnation,24 cases of yang deficiency,22 cases of heat,4 cases of cold. The common syndrome shows that 85 cases of qi deficiency and blood stasis,92 cases of phlegm and blood stasis,56 cases of yin deficiency and phlegm obstruction,86 cases of qi deficiency and phlegm obstruction,42 cases of both qi and yin deficiency and phlegm obstruction,21 cases of both qi and yin deficiency and phlegm stasis. Compare with different syndrome, there is no statistically significance in risk factor and coronary angiographic degree.
2. The characteristic of syndrome elements and common syndrome in patients with angina pectoris:for cold (dizziness, palpitation, depression, the shape of choroids) the accuracy was 0.884, sensitivity was 1.000, specifty was 0.881 and the predicative accuracy was 0.143; for qi deficiency (pale complexion, stabbing pain in the chest, cyanotic lips and tongue, soreness) the accuracy was 0.718, sensitivity was 0.722, specifty was0.741 and the predicative accuracy was 0.762; for qi stagnation, (preference for sighing, stabbing pain in the chest, edema of both lower limbs, purplish grayish tongue) the accuracy was 0.786, sensitivity was 1, specifty was0.771and the predicative accuracy was 0.241; for heat(palpitation, cyanotic lips and tongue, the color of sublingual vein, abdominal distension) the accuracy was 0.704, sensitivity was 0.909, specifty was0.679and the predicative accuracy was 0.253; for phlegm(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.762, sensitivity was 0.748, specifty was0.797and the predicative accuracy was 0.902;for yang deficiency(abdominal distension, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.704, sensitivity was 0.875, specifty was0.681and the predicative accuracy was 0.266;for yin deficiency(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.728, sensitivity was 0.795, specifty was0.692and the predicative accuracy was 0.586; for blood stasis(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.7476, sensitivity was 0.731, specifty was0.7869and the predicative accuracy was 0.8908; for qi deficiency and blood stasis (constipation, palpitation, the shape of choroids, fat body) the accuracy was 0.8204, sensitivity was 0.8947, specifty was0.8128and the predicative accuracy was 0.3269;for phlegm and blood stasis(constipation, palpitation, the shape of choroids, fat body) the accuracy was 0.7718, sensitivity was 1, specifty was0.759and the predicative accuracy was 0.1897; for yin deficiency and phlegm obstruction(constipation, palpitation, the shape of choroids, fat body) the accuracy was 0.825, sensitivity was 1.000, specifty was0.818, the predicative accuracy was 0.182; for qi deficiency and phlegm obstruction(dyspnea chest discomfort, buring sensation of five centers, preference for sighing,depression) the accuracy was 0.898, sensitivity was 1.000, specifty was 0.895 and the predicative accuracy was 0.250; for qi stagnation and blood stasis(dyspnea chest discomfort, buring sensation of five centers, preference for sighing,depression) the accuracy was 0.854, sensitivity was 1.000, specifty was 0.849 and the predicative accuracy was 0.189;for yin-asthenia and blood-stasis(palpitation, overweight and phlegmatic, constipation, thread of thought) the accuracy was 0.854, sensitivity was 1.000, specifty was 0.849 and the predicative accuracy was 0.189;for yang deficiency and phlegm obstruction(palpitation, overweight and phlegmatic, constipation, the shape of choroids) the accuracy was 0.864, sensitivity was 1.000, specifty was 0.859 and the predicative accuracy was 0.200;for qi deficiency and blood stasis and phlegm obstruction(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue) the accuracy was 0.7476, sensitivity was 0.8529, specifty was 0.7267 and the predicative accuracy was 0.3816;for both of qi and yin deficiency and phlegm obstruction(palpitation, overweight and phlegmatic, constipation, the shape of choroids) the accuracy was 0.830, sensitivity was 1.000, specifty was 0.816 and the predicative accuracy was 0.314;for both of deficiency and phlegm stasis(overweight and phlegmatic, dyspnea chest discomfort, whitish tongue fur and pale complexion) the accuracy was 0.811, sensitivity was 0.950, specifty was 0.796 and the predicative accuracy was 0.333.
3. The protein expression in sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1 in patients with coronary stable angina cordis is higher than health(P<0.01). There is no statistically meaning in sE-Selectin in both groups (p=0.067) 4. Protein expression of syndrome elements in patients with coronary stable angina cordis:The expression of tPAI-1 is higher in phlegm, stasis, qi deficiency, yin deficiency, heat; The expression of sVCAM-1 is higher in phlegm, stasis, qi deficiency, qi stagnation, yin deficiency, heat; the expression of sICAM-1 is higher in phlegm, stasis, qi deficiency, qi stagnation, yin deficiency, heat; The expression of MMP-9 is higher in phlegm, stasis, qi deficiency, qi stagnation, yin deficiency, heat; the expression of Se-Selectin is higher in phlegm, stasis, qi deficiency, yin deficiency; The expression of MPO is higher in phlegm, stasis, qi deficiency, qi stagnation, yang deficiency, heat.
5. Protein expression of syndrome in patients with coronary stable angina cordis:The expression of tPAI-1 is higher in qi deficiency and blood stasis, phlegm and blood stasis, yin deficiency and phlegm obstruction, qi deficiency and phlegm obstruction, yin deficiency and blood stasis; qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01); The expression of sVCAM-1 is higher in qi deficiency and blood stasis, phlegm and blood stasis, yin deficiency and phlegm obstruction, qi deficiency and phlegm obstruction, yin deficiency and blood stasis, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01); The expression of sICAM-1 is higher in qi deficiency and blood stasis, phlegm and blood stasis, yin deficiency and phlegm obstruction, qi deficiency and phlegm obstruction, yin deficiency and blood stasis, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01); The expression of MMP-9 is higher in qi deficiency and blood stasis, phlegm and blood stasis, phlegm and blood stasis, qi deficiency and phlegm obstruction, qi stagnation and blood stasis, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01or 0.05); The expression of Se-Selectin is higher in qi deficiency and blood stasis, phlegm and blood stasis, qi deficiency and phlegm obstruction, yin deficiency and phlegm obstruction, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01); The expression of Se-Selectin is higher than health and yang deficiency; The expression of MPO is higher in qi deficiency and blood stasis, phlegm and blood stasis, qi deficiency and phlegm obstruction, yin deficiency and phlegm obstruction, yin deficiency and blood stasis, qi deficiency and blood stasis and phlegm stagnation, both qi and yin deficiency and phlegm obstruction, both qi and yin deficiency and phlegm stasis (P<0.01);
Conclusion:
1.The common syndrome elements in patients with coronary stable angina cordis can be seen as phlegm, stasis, qi deficiency, yin deficiency, qi stagnation, yang deficiency, heat, cold; while the common syndrome can be seen as qi deficiency and blood stasis, phlegm and blood stasis, qi deficiency and phlegm obstruction, qi stagnation and blood stasis, yin deficiency and blood stasis, yang deficiency and phlegm obstruction, qi deficiency and blood stasis and phlegm obstruction, both of qi and yin deficiency and phlegm obstruction, both of qi and yin deficiency and phlegm stasis.
2.The clinical manifestation of syndrome elements in patients with coronary stable angina cordis can be summarized as following: cold(dizziness, palpitation, depression, stabbing pain in the chest, the shape of choroids); qi deficiency(pale complexion, stabbing pain in the chest, cyanotic lips and tongue, sorness); qi stagnation(preference for sighing, stabbing pain in the chest, edema of both lower limbs, purplish grayish tongue);heat (palpitation, cyanotic lips and tongue, the color of sublingual vein, abdominal distension); phlegm(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue);yang deficiency(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue);yin deficiency (abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue);blood stasis(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue);
3. The clinical manifestation of syndrome elements in patients with coronary stable angina cordis can be summarized as following: qi deficiency and blood stasis(constipation, fat body, palpitation, the shape of choroids); phlegm and blood stasis(constipation, fat body, palpitation, the shape of choroids);yin deficiency and phlegm obstruction(constipation, fat body, palpitation, the shape of choroids); yin deficiency and blood stasis(constipation, fat body, palpitation, the shape of choroids); qi deficiency and blood stasis and phlegm obstruction(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue); both of qi and yin deficiency and phlegm obstruction(abdominal distension, palpitation, the color of sublingual vein, cyanotic lips and tongue, constipation); both of qi and yin deficiency and phlegm stasis(fat body, stabbing pain in the chest, pale complexion, pale tongue).
4. The content of sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1 in patients with coronary stable angina cordis is higher than health.
5. The expression of tPAI-1, sVCAM-1, sICAM-1, sE-Selectin, MMP-9, MPO, in phlegm, stasis, qi deficiency, yin deficiency and heat increase higher; while the expression of sVCAM-1,MMP-9, MPO in qi stagnation increased significantly; MPO in yang deficiency increased.
6.The expression of sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1,sE-Selectin in qi deficiency and blood stasis, phlegm and blood stasis, yin deficiency and phlegm obstruction, qi deficiency and phlegm obstruction, yin deficiency an blood stasis increased; while the expression of sVCAM-1, sICAM-1, MMP-9, MPO in qi stagnation and blood stasis increased higher; the expression of sVCAM-1, sICAM-1, MMP-9, MPO, tPAI-1,sE-Selectin in qi deficiency and blood stasis and phlegm obstruction, both of qi and yin deficiency and phlegm stasis increases higher.
引文
1 辞海编辑委员会编.辞海[M].上海辞书出版社,1980年,1：385
2 周文泉,于向东.中医临床疗效评价的关键问题及证的量化[J].2002-第三次全国中西医结合养生学与康复医学学术研讨会
3 (汉)张仲景.伤寒论[M].北京,中医古籍出版社,1997,1：18
4 王小荣,李荣科,骆文郁.有一分恶寒未必有一分表证[J].甘肃中医学院学报,2004,21(1)：18-19
5 (汉)张仲景.伤寒论[M].北京,中医古籍出版社,1997,1：31
6 朱文锋.常见症状的计量诊病(1)[J].辽宁中医杂志,2001,28(8)：465
7 徐迪华,徐剑秋.中医量化诊断[M].南京：江苏科技出版社,1997：51
8 梁茂新,洪治平.中医症状量化的方法初探：附虚证30症的量化法[J].中国医药学报,1994,9(3)： 37
9 由松,胡立胜.中医症状及证候的量化方法探讨[J].北京中医药大学学报,2002,25(2)：13-15
10 王阶,李建生,姚魁武,等.血瘀证量化诊断及病证结合研究[J].中西医结合学报.2003,1(1)： 21-24
11 胡立胜,周强.中医临床研究设计与SAS编程统计分析[M].北京：学苑出版社,2001：61-62
12 袁肇凯,田松,李杰,等.冠心病中医证候临床实验指标的计量诊断研究[J].湖南中医学院学报,2005,25(8)：26-29
13 吴圣贤,方素钦,林炳辉,等.脑动脉硬化症的计量诊断研究[J].北京中医药大学学报,2006,29(8)：569-571
14 李晓毅.Bayes判别分析法及其在疾病诊断中的应用[J].中国卫生统计,2004,21(6)：356-357,374
15 孙亚男,宁士勇,鲁明羽,等.贝叶斯分类算法在冠心病中医临床证型诊断中的应用[J].计算机应用研究,2006,(11)：164-166
16 高怀林,吴以岭,贾振华,等.血管内皮功能障碍中医证候量化诊断标准研究[J].中国中医基础医学杂志,2008,14(4)：288-290
17 张家放主编.医用多元统计分析方法[M].武汉：华中科技大学出版社,2002：231-236.
18 高铸烨,徐浩,史大卓,等.急性心肌梗死中医辨证分型的聚类研究[J].中国中医急症,2007,16(4)：432-434
19 张月,张培彤,赵冰.基于聚类分析的肺癌中医证候分类及诊断的研究[J].北京中医药大学学报,2009,32(2)：132-135
20 何庆勇,王阶.基于聚类分析的冠心病介入术后中医证候分类及诊断[J].中医杂志.2008,49(10)： 918-921
21 陈建设,陈文垲.聚类分析结合logistic回归分析在中医证候诊断量化研究中的应用探讨[J].中国卫生统计.2009,26(04)：379-382
22 刘稼.聚类分析在中医药研究中的应用及意义[J].中医药学刊,2004,22(5)：927-928
23 朱文锋.制定全病域中医辨证量表的设计思路[J].辽宁中医杂志,2005,32(6)：521-522
Miamino T,Kitakase M,Sanada S,et al.Increased expression of P-selection on plalelets is a risk factor for silent cerebal infaction in patients with atrial fibrillation[J].Circulation,1998,98:1721-1727.
25 闫文珍,黄淑田,王瑞英,等.PAI-1和超敏CRP与代谢综合征合并冠心病关系的研究[J].医学研究杂志,2009,38(2)：43-45.
26 Jr Francis R B, Kawanishi D, Baruch T, et al. Impaired fibrinolysis in coronary artery disease. [J]. Am Heart J,1988,115(4):776-780.
27 袁肇凯,黄献平,简维雄,等.冠心病辨证与血凝纤溶系统关系的临床研究[J].云南中医学院学报,2009,32(3)：14
28 贝政平.内科疾病诊断标准[M].北京：科学出版社,2001.50-55.
29 沈绍功,王承德,闫希军.中医心病诊断疗效标准与用药规范[M].北京：北京出版社,2002.1-179.
30 孙红艳,安冬青,宋刚.冠心病秽浊痰阻证与血浆t-PA. PAI-1及Fib的相关性研究[J].中西 医结合心脑血管病杂志,2009,7(4)：389-391.
31 毛以林.冠心病血瘀证证候实质研究进展[J].中国中医药信息杂志,2002,9(10)：45-46.
Podrez E A, Abu-Soud H M, Hazen S L. Myeloperoxidase-generated oxidants and atherosclerosis.[J]. Free Radic Biol Med,2000,28(12):1717-1725.
33 卢桂静,刘文龙,李方雄,等.冠心病稳定性心绞痛患者血浆髓过氧化物酶的变化[J].中华老年医学杂志,2006,25(11)：829-831.
34 刘志远,张金盈,李纲,等.髓过氧化物酶与冠心病患者冠状动脉病变程度的关系[J].中国医药导刊,2007,9(6)：451-452.
35 曹平良,葛郁芝,盛国泰,等.髓过氧化物酶和超敏C反应蛋白在冠心病中的对比研究[J].中国心血管病研究杂志,2005,3(9)：651-652.
36 李惠,包宗明.髓过氧化物酶-463G／A基因多态性与冠心病的易患关系[J].蚌埠医学院学报,2007,32(6)：657-659.
Pajvani UB,Du X,Combs TP,et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin.Implications fpr metabolic regulation and bioactivity.Journal Biol Chem,2003,278:9073-9085.
Kumada M,Kihara S,Sumitsuji S,et al.Association of hypoadiponectinemia with coronary artery disease in men.Arterioscler Thromb Vasc Biol,2003,23:85-89.
Otsuka F,Sugiyama S,Kojima S,et al.Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease.J Am Coll Cardiol,2006,48:1155-1162.
40 王亮,潘长玉,吕吉元.高血糖合并冠心病患者血管性假性血友病因子、纤溶酶原激活剂抑制物及脂联素水平研究[J],中华老年多器官疾病杂志,2009,8(3)：240-258
41 米树华,杨秀秀,陶红.血清脂联素水平与冠心病严重程度的关系.中国介入心脏病学杂志,2009,17(3)：160-163
42 戴丽萍.冠心病患者血清脂联素和超敏c-反应蛋白测定的临床意义.现代检验医学杂志,2008,23(6)：102-104
43 刘叶,于晓玲.不同类犁冠心病患者血清脂联素水平及冠心病危险因素的变化[J].中国心血管病研究杂志,2006,4：287-289.
44斐强,秦永文,吴弘,等.血清脂联索水平与冠状动脉病变程度的关系[J].临床心血管病杂志,2004,20(10)：619.
45 张蓓蓓.冠心病中医辨证分型与血清脂联素、抵抗素及血脂水平的相关性研究[D].南京中医药大学,2006.
46 Hansson G K. Inflammation, atherosclerosis, and coronary artery disease. [J]. N Engl J Med,2005,352(16):1685-1695.
47 Shah P K. Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion.[J]. Prog Cardiovasc Dis,2002,44(5):357-368.
48 Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.[J]. Circ Res,2003,92(8):827-839.
49 Jr Woessner J F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.[J]. FASEB J,1991,5(8):2145-2154.
50 Alper O, Bergmann-Leitner E S, Bennett T A, et al. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.[J]. J Natl Cancer Inst,2001,93(18):1375-1384.
51 Watanabe N, Ikeda U. Matrix metalloproteinases and atherosclerosis.[J]. Curr Atheroscler Rep,2004,6(2):112-120.
52 Kalela A, Ponnio M, Koivu T A, et al. Association of serum sialic acid and MMP-9 with lipids and inflammatory markers.[J]. Eur J Clin Invest,2000,30(2):99-104.
53 刘晓红,来春林,胡长青,et al.冠心病患者血清MMP-9与Hcy的临床意义[J].中西医结合心脑血管病杂志,2009,7(3).
54 陈爱军,李江.冠心病患者血清MMP-9水平与血脂关系的研究[J].医学临床研究,2009,26(7)：1164-1166.
55 Hojo Y, Ikeda U, Takahashi M, et al. Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells.[J]. J Mol Cell
56 Drzewoski J, Sliwinska A, Przybylowska K, et al. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.[J]. Kardiol
Pol,2008,66(10):1042-1048,1049.
57 Derosa G, D'Angelo A, Scalise F, et al. Comparison between metalloproteinases-2 and-9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.[J]. Heart Vessels,2007,22(6):361-370. matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary
58 Furenes E B, Seljeflot I, Solheim S, et al. Long-term influence of diet and/or omega-3 fatty acids on heart disease.[J]. Scand J Clin Lab Invest,2008,68(3):177-184. disease: a prospective study in middle-aged men.[J]. QJM,2008,101(10):785-791.
59 Welsh P, Whincup P H, Papacosta O, et al. Serum matrix metalloproteinase-9 and coronary heart
60 齐振辉.血尿酸、MMP-9、hs-CRP、IL-6对急性冠脉综合征患者的临床意义[D].山西医科大学,2009.
61 吴龙川,蔡鑫,邵杉,等.冠心病患者血清sCD40L和MMP-9水平变化及其相关性研究[J].西部医学,2009,21(7).
62 鲁红霞,姜荣建.心肌梗死患者血清CRP和金属蛋白酶检测及临床意义[J].西南国防医药,2009,19(9).
63 王成,唐振旺,谭小进.Minings of IL-6 and MMP-1 in acute coronary syndrome[J].中国心血管病研究,2008(11)：828-830.
64 Tayebjee M H, Lip G Y, Tan K T, et al. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.[J]. Am J Cardiol,2005,96(3):339-345.
05 Brunner S, Kim J O, Methe H. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.[J]. Am J Cardiol,2010,105(4):429-434.
00 Cheng M, Hashmi S, Mao X, et al. Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.[J]. Can J Cardiol,2008,24(5):385-390.
67 Robertson L, Grip L, Mattsson H L, et al. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.[J]. J Intern Med,2007,262(6):659-667.
68 Jones G T, Kay I P, Chu J W, et al. Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis.[J]. Arterioscler Thromb Vasc Biol,2006,26(7):e121-e125.
69 Konstantino Y, Nguyen T T, Wolk R, et al. Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.[J]. Biomarkers,2009,14(2):118-129
70 Sluijter J P,Pulskens W P,Schoneveld A H,et al.Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions:a study in human endarterectomy specimen pointing to a role for different ext-racellular matrix metallo-proteinase inducer glycosylation forms[J].Stroke,2006,37(1):235-239.
71 徐继宾,桑圣刚.金属基质蛋白酶-9在心肌梗死患者外周血白细胞表达的研究[J].检验医学,2007,22(3)：295-297
72 徐静雯,宋晓.急性冠状动脉综合征患者血清基质金属蛋白酶-9测定的临床意义[J].中国实用医药,2009,4(14)：77
73 王援.冠心病患者血清P-选择素、纤维蛋白原检测的临床意义[J].中国社区医师.2009,11(16)：160
74 唐园园,龙明智,陈磊磊.血清可溶性P-选择素和IL-18水平与冠状动脉病变程度相关研究[J].心脏杂志.2007,19(4)：441-444,451
75 饶丹,姜红,曾秋棠,等.黏附分子E-选择素A128C基因多态性与冠心病的关系[J].心脏杂志.2007，19(5)：547-549,555
76 曾晓聪,李醒三, 文宏.冠心病患者同型半胱氨酸与C反应蛋白P选择素的相关性研究[J].中国实用内科杂志.2007,27(17)：1382-1383
77 陈昕琳,项志兵,顾仁樾.vWF、Ps水平与冠心病中医证型相关性的临床研究[J].湖北中医杂志.2007,29(8)：11-12
78 骆丽娟.冠心病证型与P2选择素,TXB2及6-Keto-PGF1a含量变化关系的研究[J].上海中医药杂,2002,(7)：13-14.
79 洪永敦,朱会英,陈宇鹏,等.冠心病痰瘀证候与E选择素G98T及S128R基因多态性的关系研究[J].广州中医药大学学报.2009,26(1)：1-5
80 龙卫平,石磊,韦爱欢,等.冠心病中医辨证分型与内皮损伤、炎症反应及血小板活化的相关性研究[J].广州中医药大学学报.2008,25(5)：457-460
81 035梁知,顼志兵,顾仁樾.冠心病中医证型与P-选择素相关性的临床研究[J].辽宁中医杂志,2006,33(12)：1595-1596
82 田敏,刘安丽,魏玉静,等.冠心病患者外周血可溶性细胞间黏附分子-l、血管细胞黏附分子-1、CD18及P选择素检测[J].郑州大学学报(医学版),2005,40(5)：900
83 马丽萍,秦永文.黏附分子与冠状动脉病变程度的相关分析[J].基础医学与临床,2004,24(1)：44
84 路岩,单玉英,姜一农,等.冠心病患者血清可溶性细胞间黏附分子-1和P选择素的变化[J].大连医科大学学报,2005,27(2)：16
Hansen PR, Role of nertrophil in myocardial ischmia and reperfusion[J]. Circulation, 1995,91:1872-1885.
86 贾宁,吴永全,贾三庆.可溶性细胞粘附分子在心血管病危险分层中的应用[J].国外医学(心血管疾病分册).2004,31(6)：329-331
87 马建波,魏任雄,李文瑞.冠心病患者血清中IL-6、slCAM-1的表达及CRP测定的临床意义[J].江西医学检验,2005,23(1)：33-35
88 李霞,方雪玲,王锡田,等.冠心病患者可溶性细胞粘附分子的检测及其临床意义[J].临床心血管病杂志.2002,18(7)：
89 Rallidis L S, Gika H I, Zolindaki M G, et al. Usefulness of elevated levels of soluble vascular cell adhesion molecule-1 in predicting in-hospital prognosis in patients with unstable angina pectoris.[J]. Am J Cardiol,2003,92(10):1195-1197.
90 Bossowska A, Kiersnowska-Rogowska B, Bossowski A, et al. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction][J]. Przegl Lek,2003,60(7):445-450.
91 石绮屏,冯烈,任强.糖尿病合并冠心病患者可溶性血管细胞黏附分子l的变化[J].中国糖尿病杂志,2006,14(2)：108,111.
92 田敏,刘安丽,魏玉静,等.冠心病患者外周血可溶性细胞间黏附分子-1、血管细胞黏附分子-1、CD18及P选择素检测[J].郑州大学学报(医学版),2005,40(5)：900-901.
93 袁肇凯,黄献平,谭光波,等.冠心病血瘀证血管内皮细胞功能的检测分析[J].中国中西医结合杂志,2006,26(5)：407-410.
94 徐济民.缺血性心脏病诊断的命名及标准——国际心脏病学会和协会／世界卫生组织临床命名标准化专题组的联合报告[J].国外医学.心血管疾病分册,1979(06)：365-366.
95 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3)：195-206.
96 中华人民共和国国家中医药管理局.中华人民共和国中医药行业标准·中医病证诊断疗效标准[M].南京：南京大学出版社.1994：18
97 中国中西医结合学会心血管病学会.冠心病中医辨证标准[J].中西医结合杂志,1991(05)：257.
98 邓铁涛主编.中医诊断学[M].第5版.上海：上海科学技术出版社.1984：80-110
99 中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版)[M].北京：人民卫生出版社,2007：17
100 中华医学会糖尿病分会.中国2型糖尿病防治指南(2007年版)[J].中华医学杂志,2008,88(18)：1227-1245.
101 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5)：390-419.
102 Gensini G G A more meaningful scoring system for determining the severity of coronary heart disease.[J]. Am J Cardiol,1983,51(3):606.
103 Moore J H, Gilbert J C, Tsai C T, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility.[J]. J Theor Biol,2006,241(2):252-261.
104 王永霞,胡宇才,朱明军,等.冠心病心绞痛中医证候分布相关性研究[J].世界中西医结合杂 志,2008,3(12)：714-716,719.
105 王永霞,胡宇才,朱明军,等.冠心病心绞痛中医证候分布相关性研究[J].世界中西医结合杂志,2008,3(12)：714-716,719.
106 王晓才,农一兵,林谦,等.138例冠心病患者的证候分布与组合特点分析[J].中医杂志,2008,49(1)：62-63,66.
107 朱明军,张建民,王永霞.冠心病心绞痛中医证候分布与白细胞介素-6、内皮素-1相关性研究[J].世界中西医结合杂志,2009,4(6)：406-408.
108 张明雪,曹洪欣,车红花,等.论冠心病的证候特征[J].国际中医中药杂志,2009,31(2)：116-117,120.
109 张琳,于鑫婷,徐浩.冠心病中医证候特点的分析与思考[J].中西医结合心脑血管病杂志,2009,7(5)：578-581.
110 王阶,邢雁伟,姚魁武,等.冠心病心绞痛中医证候要素研究及临床应用[J].湖北中医学院学报,2009,11(3)：3-5.
111 汤艳莉,王阶,何庆勇.冠心病心绞痛中医证候规律研究的比较分析[J].世界科学技术-中医药现代化,2009,11(3)：352-355.
112 李梢.从维度与阶度探讨中医证候的特征及标准化方法[J].北京中医药大学学报,2003,26(3)：1-4.
113 张秋雁,邓冰湘.冠心病心绞痛临床中医证型分布的回顾性分析[J].中医研究,2005,18(11)：23-24.
114 郭志华.冠心病心绞痛2432例中医辨证分型综合统计分析[J].湖南中医杂志,1998,14(2)：7-8.
115 衷敬柏,董绍英,王阶,等.2689例冠心病心绞痛证候要素的文献统计分析[J].中国中医药信息杂志,2006,13(5)：100-101.
116 李军.,王阶.冠心病心绞痛证候要素与应证组合的5099例文献病例分析[J].中国中医基础医学杂志,2007,13(12)：926-927,930.
117 刘华峰,程伟,李玉红.冠心病患者中医证型与冠状动脉Gensini积分、病变支数的相关性研究[J].湖北中医学院学报,2006,8(2)：10-12.
118 林谦,王晓才,农一兵,等.冠心病中医证候与冠脉病变程度的相关性研究[J].北京中医药大学学报,2007,30(12)：843-845.
119 印会河,主编.中医基础理论[M].上海科学技术出版社,2004：8
120 李先涛,张伯礼.中医证候规范研究思路和方法概况[J].辽宁中医杂志,2009,36(3)：352-354.
121 Ritchie M D, Hahn L W, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. [J]. Am J Hum Genet,2001,69(1):138-147.
122 Xuezhong Zhou, Josiah Poon, Paul Kwan, Runshun Zhang, Yinhui Wang, Simon Poon, Baoyan
Liu, and Daniel Sze, Novel Two-stage Analytic Approach in Extraction of Strong Herb-herb Interactions in TCM Clinical Treatment of Insomnia[J]. ICMB 2010,June 28-30.
123 Clausell N, Prado K F, Ribeiro J P. Increased plasma levels of soluble vascular cellular adhesion molecule-1 in patients with chest pain and angiographically normal coronary arteries.[J]. Int J Cardiol,1999,68(3):275-280.
124 徐立新,李美,张素燕.麝香保心丸对老年冠心病患者血清E-选择素、P选择素、SICAM-1、 SVCAM-1的影响[J].中药药理与临床,2005,21(1)：54-55.
125 张伟华,林钟香,何燕.舒心祛风汤对冠心病心绞痛患者血sICAM-1、 sVCAM-1和MCP-1的影响[J].上海中医药杂志,2008,42(10)：21-23.
2 周文泉,于向东.中医临床疗效评价的关键问题及证的量化[J].2002-第三次全国中西医结合养生学与康复医学学术研讨会
3 (汉)张仲景.伤寒论[M].北京,中医古籍出版社,1997,1：18
4 王小荣,李荣科,骆文郁.有一分恶寒未必有一分表证[J].甘肃中医学院学报,2004,21(1)：18-19
5 (汉)张仲景.伤寒论[M].北京,中医古籍出版社,1997,1：31
6 朱文锋.常见症状的计量诊病(1)[J].辽宁中医杂志,2001,28(8)：465
7 徐迪华,徐剑秋.中医量化诊断[M].南京：江苏科技出版社,1997：51
8 梁茂新,洪治平.中医症状量化的方法初探：附虚证30症的量化法[J].中国医药学报,1994,9(3)： 37
9 由松,胡立胜.中医症状及证候的量化方法探讨[J].北京中医药大学学报,2002,25(2)：13-15
10 王阶,李建生,姚魁武,等.血瘀证量化诊断及病证结合研究[J].中西医结合学报.2003,1(1)： 21-24
11 胡立胜,周强.中医临床研究设计与SAS编程统计分析[M].北京：学苑出版社,2001：61-62
12 袁肇凯,田松,李杰,等.冠心病中医证候临床实验指标的计量诊断研究[J].湖南中医学院学报,2005,25(8)：26-29
13 吴圣贤,方素钦,林炳辉,等.脑动脉硬化症的计量诊断研究[J].北京中医药大学学报,2006,29(8)：569-571
14 李晓毅.Bayes判别分析法及其在疾病诊断中的应用[J].中国卫生统计,2004,21(6)：356-357,374
15 孙亚男,宁士勇,鲁明羽,等.贝叶斯分类算法在冠心病中医临床证型诊断中的应用[J].计算机应用研究,2006,(11)：164-166
16 高怀林,吴以岭,贾振华,等.血管内皮功能障碍中医证候量化诊断标准研究[J].中国中医基础医学杂志,2008,14(4)：288-290
17 张家放主编.医用多元统计分析方法[M].武汉：华中科技大学出版社,2002：231-236.
18 高铸烨,徐浩,史大卓,等.急性心肌梗死中医辨证分型的聚类研究[J].中国中医急症,2007,16(4)：432-434
19 张月,张培彤,赵冰.基于聚类分析的肺癌中医证候分类及诊断的研究[J].北京中医药大学学报,2009,32(2)：132-135
20 何庆勇,王阶.基于聚类分析的冠心病介入术后中医证候分类及诊断[J].中医杂志.2008,49(10)： 918-921
21 陈建设,陈文垲.聚类分析结合logistic回归分析在中医证候诊断量化研究中的应用探讨[J].中国卫生统计.2009,26(04)：379-382
22 刘稼.聚类分析在中医药研究中的应用及意义[J].中医药学刊,2004,22(5)：927-928
23 朱文锋.制定全病域中医辨证量表的设计思路[J].辽宁中医杂志,2005,32(6)：521-522
Miamino T,Kitakase M,Sanada S,et al.Increased expression of P-selection on plalelets is a risk factor for silent cerebal infaction in patients with atrial fibrillation[J].Circulation,1998,98:1721-1727.
25 闫文珍,黄淑田,王瑞英,等.PAI-1和超敏CRP与代谢综合征合并冠心病关系的研究[J].医学研究杂志,2009,38(2)：43-45.
26 Jr Francis R B, Kawanishi D, Baruch T, et al. Impaired fibrinolysis in coronary artery disease. [J]. Am Heart J,1988,115(4):776-780.
27 袁肇凯,黄献平,简维雄,等.冠心病辨证与血凝纤溶系统关系的临床研究[J].云南中医学院学报,2009,32(3)：14
28 贝政平.内科疾病诊断标准[M].北京：科学出版社,2001.50-55.
29 沈绍功,王承德,闫希军.中医心病诊断疗效标准与用药规范[M].北京：北京出版社,2002.1-179.
30 孙红艳,安冬青,宋刚.冠心病秽浊痰阻证与血浆t-PA. PAI-1及Fib的相关性研究[J].中西 医结合心脑血管病杂志,2009,7(4)：389-391.
31 毛以林.冠心病血瘀证证候实质研究进展[J].中国中医药信息杂志,2002,9(10)：45-46.
Podrez E A, Abu-Soud H M, Hazen S L. Myeloperoxidase-generated oxidants and atherosclerosis.[J]. Free Radic Biol Med,2000,28(12):1717-1725.
33 卢桂静,刘文龙,李方雄,等.冠心病稳定性心绞痛患者血浆髓过氧化物酶的变化[J].中华老年医学杂志,2006,25(11)：829-831.
34 刘志远,张金盈,李纲,等.髓过氧化物酶与冠心病患者冠状动脉病变程度的关系[J].中国医药导刊,2007,9(6)：451-452.
35 曹平良,葛郁芝,盛国泰,等.髓过氧化物酶和超敏C反应蛋白在冠心病中的对比研究[J].中国心血管病研究杂志,2005,3(9)：651-652.
36 李惠,包宗明.髓过氧化物酶-463G／A基因多态性与冠心病的易患关系[J].蚌埠医学院学报,2007,32(6)：657-659.
Pajvani UB,Du X,Combs TP,et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin.Implications fpr metabolic regulation and bioactivity.Journal Biol Chem,2003,278:9073-9085.
Kumada M,Kihara S,Sumitsuji S,et al.Association of hypoadiponectinemia with coronary artery disease in men.Arterioscler Thromb Vasc Biol,2003,23:85-89.
Otsuka F,Sugiyama S,Kojima S,et al.Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease.J Am Coll Cardiol,2006,48:1155-1162.
40 王亮,潘长玉,吕吉元.高血糖合并冠心病患者血管性假性血友病因子、纤溶酶原激活剂抑制物及脂联素水平研究[J],中华老年多器官疾病杂志,2009,8(3)：240-258
41 米树华,杨秀秀,陶红.血清脂联素水平与冠心病严重程度的关系.中国介入心脏病学杂志,2009,17(3)：160-163
42 戴丽萍.冠心病患者血清脂联素和超敏c-反应蛋白测定的临床意义.现代检验医学杂志,2008,23(6)：102-104
43 刘叶,于晓玲.不同类犁冠心病患者血清脂联素水平及冠心病危险因素的变化[J].中国心血管病研究杂志,2006,4：287-289.
44斐强,秦永文,吴弘,等.血清脂联索水平与冠状动脉病变程度的关系[J].临床心血管病杂志,2004,20(10)：619.
45 张蓓蓓.冠心病中医辨证分型与血清脂联素、抵抗素及血脂水平的相关性研究[D].南京中医药大学,2006.
46 Hansson G K. Inflammation, atherosclerosis, and coronary artery disease. [J]. N Engl J Med,2005,352(16):1685-1695.
47 Shah P K. Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion.[J]. Prog Cardiovasc Dis,2002,44(5):357-368.
48 Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.[J]. Circ Res,2003,92(8):827-839.
49 Jr Woessner J F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.[J]. FASEB J,1991,5(8):2145-2154.
50 Alper O, Bergmann-Leitner E S, Bennett T A, et al. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.[J]. J Natl Cancer Inst,2001,93(18):1375-1384.
51 Watanabe N, Ikeda U. Matrix metalloproteinases and atherosclerosis.[J]. Curr Atheroscler Rep,2004,6(2):112-120.
52 Kalela A, Ponnio M, Koivu T A, et al. Association of serum sialic acid and MMP-9 with lipids and inflammatory markers.[J]. Eur J Clin Invest,2000,30(2):99-104.
53 刘晓红,来春林,胡长青,et al.冠心病患者血清MMP-9与Hcy的临床意义[J].中西医结合心脑血管病杂志,2009,7(3).
54 陈爱军,李江.冠心病患者血清MMP-9水平与血脂关系的研究[J].医学临床研究,2009,26(7)：1164-1166.
55 Hojo Y, Ikeda U, Takahashi M, et al. Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells.[J]. J Mol Cell
56 Drzewoski J, Sliwinska A, Przybylowska K, et al. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.[J]. Kardiol
Pol,2008,66(10):1042-1048,1049.
57 Derosa G, D'Angelo A, Scalise F, et al. Comparison between metalloproteinases-2 and-9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.[J]. Heart Vessels,2007,22(6):361-370. matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary
58 Furenes E B, Seljeflot I, Solheim S, et al. Long-term influence of diet and/or omega-3 fatty acids on heart disease.[J]. Scand J Clin Lab Invest,2008,68(3):177-184. disease: a prospective study in middle-aged men.[J]. QJM,2008,101(10):785-791.
59 Welsh P, Whincup P H, Papacosta O, et al. Serum matrix metalloproteinase-9 and coronary heart
60 齐振辉.血尿酸、MMP-9、hs-CRP、IL-6对急性冠脉综合征患者的临床意义[D].山西医科大学,2009.
61 吴龙川,蔡鑫,邵杉,等.冠心病患者血清sCD40L和MMP-9水平变化及其相关性研究[J].西部医学,2009,21(7).
62 鲁红霞,姜荣建.心肌梗死患者血清CRP和金属蛋白酶检测及临床意义[J].西南国防医药,2009,19(9).
63 王成,唐振旺,谭小进.Minings of IL-6 and MMP-1 in acute coronary syndrome[J].中国心血管病研究,2008(11)：828-830.
64 Tayebjee M H, Lip G Y, Tan K T, et al. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.[J]. Am J Cardiol,2005,96(3):339-345.
05 Brunner S, Kim J O, Methe H. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.[J]. Am J Cardiol,2010,105(4):429-434.
00 Cheng M, Hashmi S, Mao X, et al. Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.[J]. Can J Cardiol,2008,24(5):385-390.
67 Robertson L, Grip L, Mattsson H L, et al. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.[J]. J Intern Med,2007,262(6):659-667.
68 Jones G T, Kay I P, Chu J W, et al. Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis.[J]. Arterioscler Thromb Vasc Biol,2006,26(7):e121-e125.
69 Konstantino Y, Nguyen T T, Wolk R, et al. Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.[J]. Biomarkers,2009,14(2):118-129
70 Sluijter J P,Pulskens W P,Schoneveld A H,et al.Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions:a study in human endarterectomy specimen pointing to a role for different ext-racellular matrix metallo-proteinase inducer glycosylation forms[J].Stroke,2006,37(1):235-239.
71 徐继宾,桑圣刚.金属基质蛋白酶-9在心肌梗死患者外周血白细胞表达的研究[J].检验医学,2007,22(3)：295-297
72 徐静雯,宋晓.急性冠状动脉综合征患者血清基质金属蛋白酶-9测定的临床意义[J].中国实用医药,2009,4(14)：77
73 王援.冠心病患者血清P-选择素、纤维蛋白原检测的临床意义[J].中国社区医师.2009,11(16)：160
74 唐园园,龙明智,陈磊磊.血清可溶性P-选择素和IL-18水平与冠状动脉病变程度相关研究[J].心脏杂志.2007,19(4)：441-444,451
75 饶丹,姜红,曾秋棠,等.黏附分子E-选择素A128C基因多态性与冠心病的关系[J].心脏杂志.2007，19(5)：547-549,555
76 曾晓聪,李醒三, 文宏.冠心病患者同型半胱氨酸与C反应蛋白P选择素的相关性研究[J].中国实用内科杂志.2007,27(17)：1382-1383
77 陈昕琳,项志兵,顾仁樾.vWF、Ps水平与冠心病中医证型相关性的临床研究[J].湖北中医杂志.2007,29(8)：11-12
78 骆丽娟.冠心病证型与P2选择素,TXB2及6-Keto-PGF1a含量变化关系的研究[J].上海中医药杂,2002,(7)：13-14.
79 洪永敦,朱会英,陈宇鹏,等.冠心病痰瘀证候与E选择素G98T及S128R基因多态性的关系研究[J].广州中医药大学学报.2009,26(1)：1-5
80 龙卫平,石磊,韦爱欢,等.冠心病中医辨证分型与内皮损伤、炎症反应及血小板活化的相关性研究[J].广州中医药大学学报.2008,25(5)：457-460
81 035梁知,顼志兵,顾仁樾.冠心病中医证型与P-选择素相关性的临床研究[J].辽宁中医杂志,2006,33(12)：1595-1596
82 田敏,刘安丽,魏玉静,等.冠心病患者外周血可溶性细胞间黏附分子-l、血管细胞黏附分子-1、CD18及P选择素检测[J].郑州大学学报(医学版),2005,40(5)：900
83 马丽萍,秦永文.黏附分子与冠状动脉病变程度的相关分析[J].基础医学与临床,2004,24(1)：44
84 路岩,单玉英,姜一农,等.冠心病患者血清可溶性细胞间黏附分子-1和P选择素的变化[J].大连医科大学学报,2005,27(2)：16
Hansen PR, Role of nertrophil in myocardial ischmia and reperfusion[J]. Circulation, 1995,91:1872-1885.
86 贾宁,吴永全,贾三庆.可溶性细胞粘附分子在心血管病危险分层中的应用[J].国外医学(心血管疾病分册).2004,31(6)：329-331
87 马建波,魏任雄,李文瑞.冠心病患者血清中IL-6、slCAM-1的表达及CRP测定的临床意义[J].江西医学检验,2005,23(1)：33-35
88 李霞,方雪玲,王锡田,等.冠心病患者可溶性细胞粘附分子的检测及其临床意义[J].临床心血管病杂志.2002,18(7)：
89 Rallidis L S, Gika H I, Zolindaki M G, et al. Usefulness of elevated levels of soluble vascular cell adhesion molecule-1 in predicting in-hospital prognosis in patients with unstable angina pectoris.[J]. Am J Cardiol,2003,92(10):1195-1197.
90 Bossowska A, Kiersnowska-Rogowska B, Bossowski A, et al. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction][J]. Przegl Lek,2003,60(7):445-450.
91 石绮屏,冯烈,任强.糖尿病合并冠心病患者可溶性血管细胞黏附分子l的变化[J].中国糖尿病杂志,2006,14(2)：108,111.
92 田敏,刘安丽,魏玉静,等.冠心病患者外周血可溶性细胞间黏附分子-1、血管细胞黏附分子-1、CD18及P选择素检测[J].郑州大学学报(医学版),2005,40(5)：900-901.
93 袁肇凯,黄献平,谭光波,等.冠心病血瘀证血管内皮细胞功能的检测分析[J].中国中西医结合杂志,2006,26(5)：407-410.
94 徐济民.缺血性心脏病诊断的命名及标准——国际心脏病学会和协会／世界卫生组织临床命名标准化专题组的联合报告[J].国外医学.心血管疾病分册,1979(06)：365-366.
95 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3)：195-206.
96 中华人民共和国国家中医药管理局.中华人民共和国中医药行业标准·中医病证诊断疗效标准[M].南京：南京大学出版社.1994：18
97 中国中西医结合学会心血管病学会.冠心病中医辨证标准[J].中西医结合杂志,1991(05)：257.
98 邓铁涛主编.中医诊断学[M].第5版.上海：上海科学技术出版社.1984：80-110
99 中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版)[M].北京：人民卫生出版社,2007：17
100 中华医学会糖尿病分会.中国2型糖尿病防治指南(2007年版)[J].中华医学杂志,2008,88(18)：1227-1245.
101 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5)：390-419.
102 Gensini G G A more meaningful scoring system for determining the severity of coronary heart disease.[J]. Am J Cardiol,1983,51(3):606.
103 Moore J H, Gilbert J C, Tsai C T, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility.[J]. J Theor Biol,2006,241(2):252-261.
104 王永霞,胡宇才,朱明军,等.冠心病心绞痛中医证候分布相关性研究[J].世界中西医结合杂 志,2008,3(12)：714-716,719.
105 王永霞,胡宇才,朱明军,等.冠心病心绞痛中医证候分布相关性研究[J].世界中西医结合杂志,2008,3(12)：714-716,719.
106 王晓才,农一兵,林谦,等.138例冠心病患者的证候分布与组合特点分析[J].中医杂志,2008,49(1)：62-63,66.
107 朱明军,张建民,王永霞.冠心病心绞痛中医证候分布与白细胞介素-6、内皮素-1相关性研究[J].世界中西医结合杂志,2009,4(6)：406-408.
108 张明雪,曹洪欣,车红花,等.论冠心病的证候特征[J].国际中医中药杂志,2009,31(2)：116-117,120.
109 张琳,于鑫婷,徐浩.冠心病中医证候特点的分析与思考[J].中西医结合心脑血管病杂志,2009,7(5)：578-581.
110 王阶,邢雁伟,姚魁武,等.冠心病心绞痛中医证候要素研究及临床应用[J].湖北中医学院学报,2009,11(3)：3-5.
111 汤艳莉,王阶,何庆勇.冠心病心绞痛中医证候规律研究的比较分析[J].世界科学技术-中医药现代化,2009,11(3)：352-355.
112 李梢.从维度与阶度探讨中医证候的特征及标准化方法[J].北京中医药大学学报,2003,26(3)：1-4.
113 张秋雁,邓冰湘.冠心病心绞痛临床中医证型分布的回顾性分析[J].中医研究,2005,18(11)：23-24.
114 郭志华.冠心病心绞痛2432例中医辨证分型综合统计分析[J].湖南中医杂志,1998,14(2)：7-8.
115 衷敬柏,董绍英,王阶,等.2689例冠心病心绞痛证候要素的文献统计分析[J].中国中医药信息杂志,2006,13(5)：100-101.
116 李军.,王阶.冠心病心绞痛证候要素与应证组合的5099例文献病例分析[J].中国中医基础医学杂志,2007,13(12)：926-927,930.
117 刘华峰,程伟,李玉红.冠心病患者中医证型与冠状动脉Gensini积分、病变支数的相关性研究[J].湖北中医学院学报,2006,8(2)：10-12.
118 林谦,王晓才,农一兵,等.冠心病中医证候与冠脉病变程度的相关性研究[J].北京中医药大学学报,2007,30(12)：843-845.
119 印会河,主编.中医基础理论[M].上海科学技术出版社,2004：8
120 李先涛,张伯礼.中医证候规范研究思路和方法概况[J].辽宁中医杂志,2009,36(3)：352-354.
121 Ritchie M D, Hahn L W, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. [J]. Am J Hum Genet,2001,69(1):138-147.
122 Xuezhong Zhou, Josiah Poon, Paul Kwan, Runshun Zhang, Yinhui Wang, Simon Poon, Baoyan
Liu, and Daniel Sze, Novel Two-stage Analytic Approach in Extraction of Strong Herb-herb Interactions in TCM Clinical Treatment of Insomnia[J]. ICMB 2010,June 28-30.
123 Clausell N, Prado K F, Ribeiro J P. Increased plasma levels of soluble vascular cellular adhesion molecule-1 in patients with chest pain and angiographically normal coronary arteries.[J]. Int J Cardiol,1999,68(3):275-280.
124 徐立新,李美,张素燕.麝香保心丸对老年冠心病患者血清E-选择素、P选择素、SICAM-1、 SVCAM-1的影响[J].中药药理与临床,2005,21(1)：54-55.
125 张伟华,林钟香,何燕.舒心祛风汤对冠心病心绞痛患者血sICAM-1、 sVCAM-1和MCP-1的影响[J].上海中医药杂志,2008,42(10)：21-23.